SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-082608
Filing Date
2022-07-26
Accepted
2022-07-26 07:00:48
Documents
12
Period of Report
2022-07-20
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2221710d1_8k.htm   iXBRL 8-K 29362
  Complete submission text file 0001104659-22-082608.txt   204335

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA jagx-20220720.xsd EX-101.SCH 3063
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE jagx-20220720_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jagx-20220720_pre.xml EX-101.PRE 22615
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2221710d1_8k_htm.xml XML 3604
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36714 | Film No.: 221104874
SIC: 2834 Pharmaceutical Preparations